Çakmak Görür, N. (2020). Targeting the hematopoietic stem cell antigen FLT3 by high-affinity T cell receptor for the treatment of high-risk acute myeloid leukemia.
Chicago Style (17th ed.) CitationÇakmak Görür, Neşe. Targeting the Hematopoietic Stem Cell Antigen FLT3 by High-affinity T Cell Receptor for the Treatment of High-risk Acute Myeloid Leukemia. Berlin, 2020.
MLA (9th ed.) CitationÇakmak Görür, Neşe. Targeting the Hematopoietic Stem Cell Antigen FLT3 by High-affinity T Cell Receptor for the Treatment of High-risk Acute Myeloid Leukemia. 2020.
Warning: These citations may not always be 100% accurate.